William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
BYRON ALLEN'S ALLEN MEDIA GROUP ELEVATES CHRIS MALONE TO CHIEF FINANCIAL OFFICER
-
Riverside's Latest Exit Tastes Like Sweet Success
-
Sovos Brands, Inc. (SOVO) Prices 8.5M Share Secondary Offering at $14/sh
-
Sovos Brands Announces Pricing of Secondary Public Offering
-
Sovos Brands Announces Pricing of Secondary Public Offering
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Jun 30
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Jun 30
-
Shift and CarLotz Agree To Merge, Creating a Differentiated Used Auto Ecommerce Retailer
-
Shift and CarLotz Agree To Merge, Creating a Differentiated Used-Auto Ecommerce Retailer
-
Shift and CarLotz Agree To Merge, Creating a Differentiated Used-Auto Ecommerce Retailer
-
Shift and CarLotz Agree To Merge, Creating a Differentiated Used Auto Ecommerce Retailer
-
Houlihan Lokey Expands HCIT Coverage Capabilities
-
Sartorius to acquire Albumedix, creating a powerhouse for innovative advanced therapy solutions
-
Sovos Brands, Inc. (SOVO) Announces 8.5M Share Secondary Offering
-
Sovos Brands Announces Launch of Secondary Public Offering
-
Sovos Brands Announces Launch of Secondary Public Offering
-
Poseida Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Karuna Therapeutics Inc. (KRTX) Surges After Trial Meets Primary Endpoint
-
Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
-
Sartorius Stedim Biotech to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
-
William Blair Names John Kreger Director of Research
-
Form SC 13G/A HANGER, INC. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
WaterIQ Technologies™ Appoints Board of Directors to Drive Next Phase of Growth for Ultrasonic Algae and BioFilm Treatment Solutions
-
TruArc Partners Acquires Molded Devices
-
Whirlpool to buy InSinkErator for $3 billion to beef up kitchen presence
-
Explainer-What is at stake for investors in Kenya's elections?
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497 WILLIAM BLAIR FUNDS
-
CLEARLAKE CAPITAL COMPLETES SALE OF BRIGHTLY SOFTWARE TO SIEMENS
-
Poseida Therapeutics (PSTX) Prices 20M Share Offering at $3.50/sh
-
Poseida Therapeutics Announces Pricing of Public Offering of Common Stock
-
Poseida Therapeutics (PSTX) Announces Proposed Stock Offering, Size not Disclosed
-
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO
-
Poseida Therapeutics Announces Proposed Public Offering of Common Stock
-
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO
-
Poseida Therapeutics (PSTX) Announces Proposed Stock Offering, Size not Disclosed
-
Poseida Therapeutics Announces Proposed Public Offering of Common Stock
-
Sarepta's (SRPT) "Products Offer Significant Upside" - William Blair Reiterates Stock at Outperform
-
EverQuote to Participate in Upcoming Investor Conferences
-
EverQuote to Participate in Upcoming Investor Conferences
-
Greenhill & Co. Reports Second Quarter 2022 Results
-
Banner Ventures Further Expands Investment Team as Demand for Partnership Capital Grows
-
Kin Insurance Surpasses $70 Million in Gross Written Premium in Second Quarter, Increasing 204% Year-to-Date
-
Gryphon Investors Completes Majority Investment in Rootstock Software, a Leading Provider of Enterprise Resource Planning ("ERP") Software, to Accelerate Growth in Large Global ERP Market
-
William Blair Investment Management Introduces Emerging Markets ex China Growth Fund
-
OpenGov Continues Expansion with Acquisition of Operations and Asset Management Leader Cartegraph to Address the Growing Demand for Infrastructure Improvements
-
William Blair Reiterates Outperform Rating on Seagen (SGEN) Following Results from cohort K of the Phase Ib/II EV-103, Offers Comments
-
KKR Completes Majority Investment in apexanalytix Alongside Carousel Capital
-
Verve Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Verve Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

